As more employers make the switch, pressure will mount on these conglomerates to either reform or lose market share. The writing is on the wall. The traditional PBM model is doomed to be a shell ...

EST Psyence Biomedical (PBM) files to sell 3.075M common shares for holdersInvest with Confidence: Follow TipRanks' Top Wall Street ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

Unlike a PBM, BSC will pay Evio a flat fee to negotiate ... or lists of therapeutics covered by insurance. This in turn drives market share towards heavily rebated prescription drugs.